When a global pandemic strikes, it’s important to use the resources at your disposal to help others. According to a recent FiercePharma article, Swiss-based pharma giant Novartis is doing its part by promising zero profit from sales of 15 generic and over-the-counter drugs that manage COVID-19 symptoms in developing countries. The medicines, all from Novartis’ Sandoz unit, include widely used antibiotics and anti-inflammatory therapies and medications for cardiovascular and gastrointestinal diseases. On top of that, Novartis has pledged to donate $40 million to support communities affected by the pandemic.
Novartis to Forgo COVID-19 Profits in Developing Countries
The company’s generic division will offer 15 medicines at zero profit.
Jul 22, 2020
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
